Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Sniderman: Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia.... (0.13 sec) 

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 …

- annals.org [PDF] 
AD Sniderman, T Scantlebury, K Cianflone - Annals of internal medicine, 2001 - Am Coll Physicians
Abnormalities in insulin and glucose metabolism do not seem to entirely account
for the high frequency of cardiovascular disease in patients with type 2
diabetes mellitus. An important additional factor may be ...
Cited by 277 - Related articles - BL Direct - All 10 versions

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment


AD Sniderman, CD Furberg, A Keech, JER van … - The Lancet, 2003 - Elsevier
The Apolipoprotein-related Mortality Risk Study (AMORIS) 2 was designed to
compare concentrations of LDL cholesterol and apolipoprotein B as predictors of
fatal acute myocardial infarction in 175 553 adults followed up for 5·5 ...
Cited by 282 - Related articles - All 5 versions

High apolipoprotein B, low apolipoprotein AI, and improvement in the prediction of fatal …

- uu.se [PDF] 
G Walldius, I Jungner, I Holme, AH Aastveit, W … - The Lancet, 2001 - Elsevier
Mean follow-up was 66·8 months (SD 41·3) for 98722 men and 64·4 months
(41·4) for 76831 women. 864 men and 359 women had fatal myocardial infarction.
In univariate analyses adjusted for age and in multivariate analyses ...
Cited by 575 - Related articles - BL Direct - All 8 versions

Apolipoprotein concentrations during treatment and recurrent coronary artery disease …

- ahajournals.org
JER van Lennep, HT Westerveld, HWO van … - Arteriosclerosis, thrombosis, and vascular biology, 2000 - Am Heart Assoc
Abstract—The effect of untreated total cholesterol (TC) and low density
lipoprotein cholesterol (LDL-C) as cardiovascular risk factors in both primary
and secondary prevention has been extensively investigated. The predictive ...
Cited by 125 - Related articles - BL Direct - All 7 versions

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart …

- ahajournals.org
PJ Talmud, E Hawe, GJ Miller, SE Humphries - Arteriosclerosis, thrombosis, and vascular biology, 2002 - Am Heart Assoc
Methods and Results— Healthy middle-aged men (n=2508), free of CHD at
baseline, were examined prospectively. Over 6 years of follow-up, there were 163
CHD events (including acute myocardial infarction, coronary artery surgery, ...
Cited by 151 - Related articles - BL Direct - All 5 versions

Relation between baseline and on-treatment lipid parameters and first acute major …

- ahajournals.org
AM Gotto Jr, E Whitney, EA Stein, DR Shapiro … - Circulation, 2000 - Am Heart Assoc
Background—The Air Force/Texas Coronary Atherosclerosis Prevention Study
(AFCAPS/TexCAPS) is the first primary-prevention study in a cohort with average
total cholesterol (TC) and LDL cholesterol (LDL-C) and below-average HDL ...
Cited by 416 - Related articles - BL Direct - All 5 versions

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial


AD Sniderman, J Bergeron, J Frohlich - Canadian Medical Association Journal, 2001 - ecmaj.ca
In his Nobel laureate address, Joseph Goldstein referred to cholesterol as the
most decorated molecule in history, 1 and certainly there is a lot of evidence
relating the levels of total and low-density lipoprotein (LDL) cholesterol ...
Cited by 18 - Related articles - BL Direct - All 12 versions

Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol …

- ahajournals.org
K Williams, AD Sniderman, N Sattar, R D' … - Circulation, 2003 - Am Heart Assoc
Methods and Results— In 1522 individuals in the Insulin Resistance
Atherosclerosis Study, anthropometric measures and measures of lipids, apoB,
C-reactive protein, fibrinogen, plasminogen activator inhibitor-1 (PAI-1), ...
Cited by 88 - Related articles - BL Direct - All 6 versions

Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 …


AM Wägner, A Pérez, E Zapico, J Ordóñez- … - Diabetes Care, 2003 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Total cholesterol and triglycerides, HDLc, LDL
cholesterol, non-HDLc, apolipoprotein B (apoB), and LDL size were determined in
122 type 2 diabetic patients (68% male, aged 59.6 ± 9.7 years, and HbA 1c ...
Cited by 40 - Related articles - BL Direct - All 5 versions

Measurement issues related to lipoprotein heterogeneity


JD Otvos, EJ Jeyarajah, WC Cromwell - The American journal of cardiology, 2002 - Elsevier
In clinical practice, the coronary artery disease (CAD) risk associated with
high levels of low-density lipoprotein (LDL) or low levels of high-density
lipoprotein (HDL) is assessed not by measuring LDL and HDL particles ...
Cited by 119 - Related articles - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google